Erratum: Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects (American Society for Clinical Investigation (2015) 125:6 (2510-2522) DOI: 10.1172/JCI80025)

John S. Millar, Gissette Reyes-Soffer, Patricia Jumes, Richard L. Dunbar, Emil M. DeGoma, Amanda L. Baer, Wahida Karmally, Daniel S. Donovan, Hashmi Rafeek, Laura Pollan, Junichiro Tohyama, Amy O. Johnson-Levonas, John A. Wagner, Stephen Holleran, Joseph Obunike, Yang Liu, Rajasekhar Ramakrishnan, Michael E. Lassman, David E. Gutstein, Henry N. GinsbergDaniel J. Rader

Research output: Contribution to journalComment/debatepeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)1603-1604
Number of pages2
JournalJournal of Clinical Investigation
Volume126
Issue number4
DOIs
Publication statusPublished - Apr 1 2016

ASJC Scopus Subject Areas

  • General Medicine

Cite this

Millar, J. S., Reyes-Soffer, G., Jumes, P., Dunbar, R. L., DeGoma, E. M., Baer, A. L., Karmally, W., Donovan, D. S., Rafeek, H., Pollan, L., Tohyama, J., Johnson-Levonas, A. O., Wagner, J. A., Holleran, S., Obunike, J., Liu, Y., Ramakrishnan, R., Lassman, M. E., Gutstein, D. E., ... Rader, D. J. (2016). Erratum: Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects (American Society for Clinical Investigation (2015) 125:6 (2510-2522) DOI: 10.1172/JCI80025). Journal of Clinical Investigation, 126(4), 1603-1604. https://doi.org/10.1172/JCI87342